Fedex (FDX) Shareholder Hudson Valley Investment Advisors Increased Holding by $435,840 as Market Valuation Declined; Abbvie (ABBV) Stake Has Lifted by Alley Company Llc

June 18, 2018 - By Richard Conner

FedEx Corporation (NYSE:FDX) Logo

Hudson Valley Investment Advisors Inc increased its stake in Fedex Corporation (FDX) by 15.23% based on its latest 2018Q1 regulatory filing with the SEC. Hudson Valley Investment Advisors Inc bought 1,816 shares as the company’s stock declined 1.18% with the market. The institutional investor held 13,741 shares of the air freight and delivery services company at the end of 2018Q1, valued at $3.30 million, up from 11,925 at the end of the previous reported quarter. Hudson Valley Investment Advisors Inc who had been investing in Fedex Corporation for a number of months, seems to be bullish on the $70.35 billion market cap company. The stock decreased 0.49% or $1.3 during the last trading session, reaching $263.26. About 625,863 shares traded. FedEx Corporation (NYSE:FDX) has risen 29.10% since June 18, 2017 and is uptrending. It has outperformed by 16.53% the S&P500. Some Historical FDX News: 20/03/2018 – FedEx delivers earnings beat on more shipments, higher rates; 20/03/2018 – FEDEX CORP QTRLY GROUND SEGMENT GAAP REV $5.22 BLN VS $4.69 BLN REPORTED LAST YEAR; 21/03/2018 – Tony Plohetski: BREAKING: Authorities responding to FedEx facility in Austin for suspicious package. Call came in at 9:32; 20/03/2018 – BNO News: BREAKING: A package which was found at a FedEx facility in southeast Austin contains a bomb, U.S. Congressman; 16/05/2018 – Express Delivery Market in Brazil to Reach $7.68 Billion by 2022 – Key Players are Correios, DHL Group, FedEx, Nippon Express, and UPS – ResearchAndMarkets.com; 26/03/2018 – FEDEX CORP – FULLY-ELECTRIC TRUCKS, WHICH ARE SCHEDULED TO BEGIN PRODUCTION IN 2019, WILL BE OPERATED BY FEDEX FREIGHT, ITS LESS-THAN-TRUCKLOAD UNIT; 15/03/2018 – DHL Steps Back Into U.S. Package Delivery in Challenge to UPS, FedEx; 20/03/2018 – FedEx 3Q EPS $2.07; 20/03/2018 – Global News Toronto: BREAKING: A package containing nails and shrapnel exploded at a FedEx centre in Texas early Tuesday; 20/03/2018 – FEDEX SEES EFFECTIVE TAX RATE 20%-21% IN FISCAL 2018

Alley Company Llc increased its stake in Abbvie Inc (ABBV) by 106.81% based on its latest 2018Q1 regulatory filing with the SEC. Alley Company Llc bought 43,884 shares as the company’s stock declined 16.83% with the market. The institutional investor held 84,970 shares of the major pharmaceuticals company at the end of 2018Q1, valued at $8.04 million, up from 41,086 at the end of the previous reported quarter. Alley Company Llc who had been investing in Abbvie Inc for a number of months, seems to be bullish on the $149.39 billion market cap company. The stock decreased 0.90% or $0.9 during the last trading session, reaching $98.67. About 1.95M shares traded. AbbVie Inc. (NYSE:ABBV) has risen 52.41% since June 18, 2017 and is uptrending. It has outperformed by 39.84% the S&P500. Some Historical ABBV News: 05/04/2018 – AbbVie Announces Global Resolution of HUMIRA® (adalimumab) Patent Disputes with Samsung Bioepis; 25/04/2018 – Protocols: AbbVie advances its two star pipeline therapies, filing BLA for risankizumab and posting promising data for upadacitinib $ABBV; 18/04/2018 – Nuveen Dividend Value Adds Bank of America, Cuts AbbVie; 10/04/2018 – ABBV,NBIX: FDA REQUIRES EXTENDED TIME FOR REVIEW OF NDA; 30/04/2018 – AbbVie’s Mavyret Rises After 1-Wk Fall, Epclusa Advances: Hep-C; 21/05/2018 – LANNETT – EXPECT TO COMMENCE MARKETING SEVERAL PRODUCTS INCLUDING DRONABINOL CAPSULES OVER COURSE OF YEAR; 25/05/2018 – Oncolytics Biotech Collaborates With USC Using Pelareorep in Combination With Keytruda, Velcade and Dexamethasone to Treat Multiple Myeloma; 21/05/2018 – Gilead’s Harvoni Falls After 2-Wk Rise, Epclusa Declines: Hep-C; 25/04/2018 – ABBVIE INC – SIGNIFICANTLY MORE PATIENTS RECEIVING UPADACITINIB ACHIEVED ACR50, ACR70 AND CLINICAL REMISSION AT WEEK 12 COMPARED TO PLACEBO; 22/03/2018 – ABBV CITES MAGNITUDE OF EFFECT ACROSS MULTIPLE STUDY PARAMETERS

Since December 18, 2017, it had 0 insider buys, and 9 insider sales for $25.06 million activity. Another trade for 1,337 shares valued at $157,458 was made by SALEKI-GERHARDT AZITA on Wednesday, February 28. CHASE WILLIAM J had sold 70,928 shares worth $8.31M. 83,574 shares were sold by ALBAN CARLOS, worth $9.57 million on Wednesday, February 28. $2.95M worth of AbbVie Inc. (NYSE:ABBV) was sold by Schumacher Laura J. Shares for $2.15M were sold by RICHMOND TIMOTHY J.. SEVERINO MICHAEL sold 2,643 shares worth $311,684.

More notable recent AbbVie Inc. (NYSE:ABBV) news were published by: Seekingalpha.com which released: “AbbVie: Growth And Dividend In One Package” on June 15, 2018, also Seekingalpha.com with their article: “More Thoughts On AbbVie’s Rova-T Implosion” published on June 06, 2018, Seekingalpha.com published: “Premarket analyst action – healthcare” on June 01, 2018. More interesting news about AbbVie Inc. (NYSE:ABBV) were released by: Fool.com and their article: “Better Buy: AbbVie Inc. vs. GlaxoSmithKline plc” published on June 15, 2018 as well as Globenewswire.com‘s news article titled: “Analysis: Positioning to Benefit within Canopy Growth, Aurora Cannabis, CannTrust, AbbVie, Cronos Group, and Scotts …” with publication date: June 15, 2018.

Among 24 analysts covering Abbvie Inc (NYSE:ABBV), 9 have Buy rating, 3 Sell and 12 Hold. Therefore 38% are positive. Abbvie Inc had 96 analyst reports since July 21, 2015 according to SRatingsIntel. The company was upgraded on Monday, October 2 by Leerink Swann. BMO Capital Markets downgraded the stock to “Underperform” rating in Tuesday, January 30 report. As per Thursday, March 22, the company rating was maintained by Leerink Swann. The firm has “Hold” rating given on Monday, January 29 by Leerink Swann. The rating was maintained by Jefferies on Friday, March 23 with “Buy”. The firm has “Buy” rating by Goldman Sachs given on Monday, March 7. The firm earned “Buy” rating on Friday, January 26 by Cowen & Co. The stock of AbbVie Inc. (NYSE:ABBV) earned “Buy” rating by Piper Jaffray on Friday, September 15. BMO Capital Markets maintained the shares of ABBV in report on Wednesday, October 11 with “Hold” rating. The firm has “Buy” rating given on Friday, January 26 by Jefferies.

Investors sentiment decreased to 0.7 in 2018 Q1. Its down 0.10, from 0.8 in 2017Q4. It dived, as 61 investors sold ABBV shares while 737 reduced holdings. 127 funds opened positions while 428 raised stakes. 1.06 billion shares or 0.67% less from 1.06 billion shares in 2017Q4 were reported. Wheatland Advsr Incorporated holds 7,540 shares. Waters Parkerson Company Ltd has invested 0.03% in AbbVie Inc. (NYSE:ABBV). Peoples reported 1.21% stake. Bonness Inc has invested 2.41% in AbbVie Inc. (NYSE:ABBV). The Luxembourg-based Pictet Cie (Europe) Sa has invested 0.08% in AbbVie Inc. (NYSE:ABBV). Hartline Inv invested in 8,569 shares or 0.23% of the stock. Biondo Inv Advisors Ltd Co owns 63,251 shares. Tdam Usa holds 358,128 shares. Plancorp Limited Com, Missouri-based fund reported 18,169 shares. New Mexico Educational Retirement Board has invested 0.55% in AbbVie Inc. (NYSE:ABBV). Roundview Lc has invested 0.24% in AbbVie Inc. (NYSE:ABBV). Garde Capital holds 0.24% or 13,709 shares. Wealthtrust holds 0% of its portfolio in AbbVie Inc. (NYSE:ABBV) for 55 shares. Rhumbline Advisers holds 0.48% or 2.45M shares in its portfolio. Ing Groep Nv stated it has 0.6% in AbbVie Inc. (NYSE:ABBV).

Alley Company Llc, which manages about $325.81 million and $291.43M US Long portfolio, decreased its stake in Cme Group Inc (NASDAQ:CME) by 2,000 shares to 27,535 shares, valued at $4.45 million in 2018Q1, according to the filing. It also reduced its holding in Amazon Com Inc (NASDAQ:AMZN) by 275 shares in the quarter, leaving it with 4,266 shares, and cut its stake in Exxon Mobil Corp (NYSE:XOM).

Investors sentiment decreased to 1 in Q1 2018. Its down 0.21, from 1.21 in 2017Q4. It is negative, as 58 investors sold FDX shares while 414 reduced holdings. 113 funds opened positions while 359 raised stakes. 192.41 million shares or 0.69% less from 193.75 million shares in 2017Q4 were reported. Moreover, Echo Street Capital Mngmt Ltd Co has 0.33% invested in FedEx Corporation (NYSE:FDX). Fairfield Bush & holds 0.71% or 10,205 shares. 2,096 are held by Amica Mutual Ins Com. Avalon Advisors Limited Liability owns 40,747 shares. Pettee Investors Inc holds 0.4% of its portfolio in FedEx Corporation (NYSE:FDX) for 2,665 shares. Hartford Inv Management Co holds 47,507 shares or 0.23% of its portfolio. Retirement System Of Alabama has invested 0.29% in FedEx Corporation (NYSE:FDX). Chem Bancorporation accumulated 13,821 shares. Lsv Asset Mgmt stated it has 0.65% of its portfolio in FedEx Corporation (NYSE:FDX). Pictet Asset Mgmt Limited has invested 0.08% of its portfolio in FedEx Corporation (NYSE:FDX). Country Club Tru Communication Na holds 0.23% or 7,778 shares. 400 are owned by Orrstown Finance Incorporated. Weiss Multi owns 2,052 shares. First Natl Trust, a Pennsylvania-based fund reported 3,169 shares. Whitnell And Comm accumulated 25 shares.

Hudson Valley Investment Advisors Inc, which manages about $579.98M and $396.79M US Long portfolio, decreased its stake in Medtronic Plc (NYSE:MDT) by 4,973 shares to 151,145 shares, valued at $12.13M in 2018Q1, according to the filing. It also reduced its holding in Sterling Bancorp Del Com (NYSE:STL) by 18,499 shares in the quarter, leaving it with 363,491 shares, and cut its stake in Starbucks Corp (NASDAQ:SBUX).

Since January 2, 2018, it had 1 buying transaction, and 4 selling transactions for $45.54 million activity. On Tuesday, February 6 SCHWAB SUSAN C bought $19,837 worth of FedEx Corporation (NYSE:FDX) or 80 shares. $1.12M worth of FedEx Corporation (NYSE:FDX) shares were sold by WALSH PAUL S. Shares for $11.89 million were sold by BRONCZEK DAVID J on Tuesday, January 2. Another trade for 124,000 shares valued at $31.74 million was made by SMITH FREDERICK W on Wednesday, April 18.

FedEx Corporation (NYSE:FDX) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>